AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glykris M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Krishbaj India Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glykris M 2mg/500mg Tablet SR

Diabetic patients using the extended-release Glykris M 2mg/500mg tablet, an anti-diabetic combination medication, manage type 2 diabetes mellitus. This dual-action drug regulates blood glucose levels in adults. Administer this medication with food, consistently at the same time daily for optimal results. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use, even with controlled blood sugar, is crucial. Discontinuing treatment without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor; lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry readily available glucose sources. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain is also possible. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment; pregnancy or breastfeeding also necessitates consultation. Regular blood glucose monitoring is essential, along with periodic blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glykris M 2mg/500mg Tablet SR

No text provided. Please provide the text you would like me to rephrase.

Uses of Glykris M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glykris M 2mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glykris M 2mg/500mg Extended-Release tablets should be administered with a meal.

Common Side effects of Glykris M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glykris M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glykris M 2mg/500mg Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

How Glykris M 2mg/500mg Tablet SR works:

Glykris M 2mg/500mg sustained-release tablets contain glimepiride and metformin, two agents used to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glykris M 2mg/500mg SR tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glykris M 2mg/500mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glykris M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar abnormalities.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glykris M 2mg/500mg SR tablets; dosage modification may be necessary. Severe kidney disease contraindicates the use of Glykris M 2mg/500mg SR tablets. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Glykris M 2mg/500mg SR tablets. Dosage modifications may be necessary for Glykris M 2mg/500mg SR tablets. Physician consultation is advised. In individuals with mild to moderate hepatic dysfunction, Glykris M 2mg/500mg SR tablets are typically initiated at a reduced dosage; however, their use is contraindicated in those with severe liver disease.

What if you forget to take Glykris M 2mg/500mg Tablet SR :

Should you forget a Glykris M 2mg/500mg Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glykris M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glykris M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Glykris M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glykris M and seek immediate medical attention.
Glykris M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glykris M is not suitable for type 1 diabetes.
Glykris M 2mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach ache, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glykris M 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glykris M 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glykris M 2mg/500mg SR tablets and alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glykris M 2mg/500mg Table...
70
MRP 85
17% off